RecruitingNCT07313410

Using Near-Infrared Light to Better Understand Peripheral Artery Disease

Near-Infrared Diffuse Correlation Spectroscopy to Better Define the Pathophysiology of Peripheral Artery Disease


Sponsor

The University of Texas at Arlington

Enrollment

120 participants

Start Date

Nov 1, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

The goal of this study is to better understand how blood flows and how oxygen is utilized in the lower limbs of people who suffer from peripheral artery disease. This study will also assess how these factors affect treatment outcomes. Specific aims include: Aim 1: Utilize BB-NIR-DCS to differentiate PAD patients experiencing primary oxygen delivery limitations from those suffering from mitochondrial dysfunction. Aim 2: Test the efficacy of BB-NIR-DCS at predicting individual responses to vascular intervention.


Eligibility

Min Age: 18 Years

Inclusion Criteria9

  • Cases, Aim 1
  • or older
  • willing to participate under the conditions described in the informed consent form (ICF)
  • eligible to sign the ICF
  • established diagnosis of PAD confirmed by a physician
  • able to comply with the study requirements
  • Cases, Aim 2
  • \) completed Aim 1
  • Controls 1) asymptomatic, with no history or diagnosis of peripheral artery disease

Exclusion Criteria11

  • Cases, Aim 1
  • Ankle-Brachial Index \>0.9 or \<0.4
  • isolated disease in aorta/iliac vessels
  • unstable angina or myocardial infarction in past 12 months
  • orthopedic or other physical limitations which would prevent data collection
  • contraindications to MRI, including presence of a Pacemaker, presence of bone growth/ bone fusion stimulators, presence of tissue expander, presence of cochlear implants, unable to ambulate for 10 feet, receiving continuous Oxygen therapy, pregnancy, permanent Jewelry (screened using MRI safety screening form and verbal screening by MRI operator
  • Cases, Aim 2
  • unstable angina or myocardial infarction in past 12 months
  • orthopedic or other physical limitations which would prevent data collection
  • contraindications to MRI, including presence of a pacemaker, presence of bone growth/ bone fusion stimulators, presence of tissue expander, presence of cochlear implants, unable to ambulate for 10 feet, receiving continuous Oxygen therapy, pregnancy, permanent Jewelry (screened using MRI safety screening form and verbal screening by MRI operator).
  • Controls 1) history of peripheral artery disease 2) overt cardiovascular disease (e.g. heart failure) 3) known pulmonary disease (excluding mild asthma) 4) current tobacco use 5) orthopedic or other physical limitations which would prevent data collection, 6) BP \>150/90 mmHg at screening 7) contraindications to MRI, including presence of a pacemaker, presence of bone growth/ bone fusion stimulators, presence of tissue expander, presence of cochlear implants, unable to ambulate for 10 feet, receiving continuous Oxygen therapy, pregnancy, permanent Jewelry (screened using MRI safety screening form and verbal screening by MRI operator).

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(2)

University of Texas at Arlington

Arlington, Texas, United States

University of Texas Arlington

Arlington, Texas, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07313410


Related Trials